Biopharma Business

Vaccines

Rapid Micro Biosystems to develop final implementation of rapid sterility test for vaccines

    Rapid Micro Biosystems to develop final implementation of rapid sterility test for vaccines

The company as been awarded the contract by the US Biomedical Advanced Research and Development Authority (BARDA). Rapid Micro Biosystems, a provider of automated, non-destructive, rapid microbial detection, has received

Read Full Article

Lilly signs up to cancer vaccines with CureVac deal

    Lilly signs up to cancer vaccines with CureVac deal

Eli Lilly has signed up CureVac to develop cancer vaccines based on its mRNA technology, in a deal that could potentially be worth more than $2.6 billion to the German

Read Full Article

Development of new respiratory syncytial virus vaccine

    Development of new respiratory syncytial virus vaccine

SGS announced it has entered into collaboration with Bavarian Nordic A/S, an international biotechnology company specialising in vaccines, to develop a new respiratory syncytial virus (RSV) challenge strain. This will

Read Full Article

Researchers seek 500 NHS patients to test new universal flu jab

    Researchers seek 500 NHS patients to test new universal flu jab

The BBC has reported that researchers from the University of Oxford’s Jenner Institute are seeking 500 NHS patients to test a new ‘universal’ vaccine for seasonal influenza, which may give

Read Full Article

Pfizer’s Meningococcal Group B vaccine, Trumenba, gets approval in Europe

    Pfizer’s Meningococcal Group B vaccine, Trumenba, gets approval in Europe

Pfizer has secured approval the European Commission (EC) for TRUMENBA (Meningococcal Group B Vaccine) for preventing invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB) in individuals 10 years

Read Full Article

Promising Preclinical Results of Zika Virus Vaccine

    Promising Preclinical Results of Zika Virus Vaccine

  Preclinical results of research by City College of New York scientists and TechnoVax, Inc. in animal models demonstrate favorable outcomes in developing a vaccine against the mosquito-borne Zika virus.

Read Full Article

HIV market to grow to $22.5bn by 2025

This growth is across the nine major countries of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil and China The human immunodeficiency virus (HIV) market is set to

Read Full Article

Norway Brings Another Cancer Vaccine to the Clinic

Targovax has recruited its first patient in a Phase Ib trial for its new cancer vaccine TG02 targeting mutations of the RAS gene. Mutations of the RAS gene disrupt normal cell

Read Full Article

Italy Adopts Gender-Neutral HPV Vaccination Program

Italy adopts gender-neutral HPV vaccination program, citing study by health economics expert from Kingston University London’s Business School. The Italian government has changed its policy to allow both boys and

Read Full Article

Nemaura secures funding for drug delivery system

Biotech company Nemaura Pharma has secured up to £5 million funding from private investors for the development of a hormone biologic using its Micro-Patch solid dose delivery platform. The company’s

Read Full Article

Upcoming Events

  • November 12, 2018Compamed
  • November 13, 2018Foodpharmatech
  • April 21, 2019Labvolution
AEC v1.0.4

The Magazine

New Subscriber





Subscribe Here



Advertisements